重视规范化处理门静脉高压并发食管胃静脉曲张出血*

doi:10.3969/j.issn.1672-5069.2023.01.001

Abstract

Huang Xiaoquan, Chen Shiyao. Standardization treatment of patients with portal hypertension and gastroesophageal variceal bleeding[J]. Journal of Practical Hepatology, 2023, 26(1): 1-3.

[1] de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol, 2022, 76(4):959-974.
[2] Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology, 2017, 65(1):310-335.
[3] Villanueva C, Albillos A, Genescà J, et al.β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet, 2019, 393(10181):1597-1608.
[4] 黄晓铨,吴玲,姜思雨,等.食管静脉曲张出血的急诊内镜治疗选择与疗效评价.中国医师杂志,2022,24(5):653-657.
[5] Tseng Y, Ma L, Luo T, et al. Patient response to endoscopic therapy for gastroesophageal varices based on endoscopic ultrasound findings. Gut Liver, 2018, 12(5):562-570.
[6] 李冰,罗剑钧,张雯,等. 极高肝静脉压力梯度对食管胃静脉曲张二级预防患者内镜治疗短期预后的影响.中华消化杂志,2017,37(10):655-660.
[7] 黄晓铨,倪礼爰,姜思雨,等.门静脉血栓影响内镜治疗预防乙型肝炎肝硬化食管胃静脉曲张破裂再出血的疗效.中华肝脏病杂志,2020,28(9):747-752.
[8] 罗添成,黄晓铨,夏睿琦,等. 不明原因门脉高压食管胃静脉曲张患者的临床病理特征与内镜治疗.中国医师杂志,2021,23(3):324-327,332.
[9] Huang X, Li F, Wang L, et al. Endoscopic treatment of gastroesophageal variceal bleeding after oxaliplatin-based chemotherapy in patients with colorectal cancer. Endoscopy, 2020, 52(9):727-735.
[10] Huang X, Zhang M, Ai Y, et al. Characteristics of myeloproliferative neoplasm-associated portal hypertension and endoscopic management of variceal bleeding. Ther Adv Chronic Dis, 2022, 13:20406223221125691.

[1]	Lai Ruimin, Zhu Yuejiu. Portal hypertension: indication of transjugular intrahepatic portosystemic shunt and the prevention of related complications [J]. Journal of Practical Hepatology, 2023, 26(1): 4-7.
[2]	Xu Qing, Yang Jian, Zong Jinjuan. Imaging and histopathological features in patients with idiopathic non-cirrhotic portal hypertension [J]. Journal of Practical Hepatology, 2023, 26(1): 91-94.
[3]	Zhang Wei, Hou Wei, Liu Hui, et al. Recurrence three years after liver transplantation of patients with idiopathic portal hypertension: A case report and literature review [J]. Journal of Practical Hepatology, 2023, 26(1): 136-139.
[4]	Yang Jing, Cheng Yanli. Idiopathic non-cirrhotic portal hypertension: one case report and literature review [J]. Journal of Practical Hepatology, 2022, 25(5): 750-752.
[5]	He Wei, Zhang Xiaobin, Liu Yingdi, et al. Clinical features of patients with gastroesophageal varices under 30 years old [J]. Journal of Practical Hepatology, 2022, 25(4): 550-553.
[6]	He Fuliang, Ma Lin, Li Yuerong, et al. Non-cirrhotic portal hypertension:the highlight of its diagnosis [J]. Journal of Practical Hepatology, 2022, 25(1): 1-4.
[7]	Chen Jing, Zhu Yueyong. Non-invasive diagnosis of portal hypertension in patients with liver cirrhosis: serum markers or imaging? [J]. Journal of Practical Hepatology, 2022, 25(1): 9-12.
[8]	Wu Ling, Li Feng. Administration of non-selective beta-blockers in treatment of patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2022, 25(1): 144-147.
[9]	Zhao Jianbo, Tan Qing. Non-cirrhotic portal hypertension: current state [J]. Journal of Practical Hepatology, 2021, 24(5): 613-616.
[10]	Liu Gongwei, Wu Xue, Tang Dan, et al. Re-observation of splenectomy and esophagogastric devascularization in patients with hepatitis B cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2021, 24(5): 649-652.
[11]	Wang Yunqiang, Wang Liping, Huang Dongmei, et al. Changes ofportal hemodynamics in patients with hepatitis B cirrhosis after transjugular intrahepatic portosystemic stent-shunt [J]. Journal of Practical Hepatology, 2021, 24(3): 399-402.
[12]	Zhou Hui, Feng Xiaoning, Ren Hao, et al. Clinical features and hepatic venous pressure gradientchanges in patients with noncirrhotic portal hypertension [J]. Journal of Practical Hepatology, 2021, 24(3): 415-418.
[13]	Zhao Kai, Xue Jinfeng, Xue Pengfei, et al. Application of Viatorr covered stent in TIPS for treatment of cirrhotics with portal hypertension [J]. Journal of Practical Hepatology, 2021, 24(3): 419-422.
[14]	Wu Ronggang, Zhang Biquan, Wang Zhen. Value of CT-detected portal parameters in the diagnosis of significant clinical portal hypertension and predicting variceal bleeding in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2020, 23(6): 853-856.
[15]	Li Shuang, Liu Jinyu, Wu Xiaoyu, et al. Depletion of intrahepatic macrophages by clodronate liposomes in rats with CCl₄-induced chronic liver injury and portal hypertension [J]. Journal of Practical Hepatology, 2020, 23(4): 484-487.

Standardization treatment of patients with portal hypertension and gastroesophageal variceal bleeding

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments